Myovant Sciences Ltd. Common Shares (MYOV): Stock Offering News

MYOV – Commences underwritten public offering of $75 mln of its common shares.


Key Facts Surrounding This News Item


  • MYOV had a POWR Rating of B (Buy) coming into today.
  • MYOV was -0.13% below its 10-Day Moving Average coming into today.
  • MYOV was -0.18% below its 20-Day Moving Average coming into today.
  • MYOV was 5.22% above its 50-Day Moving Average coming into today.
  • MYOV was 15.19% above its 100-Day Moving Average coming into today.
  • MYOV was 38.82% above its 200-Day Moving Average coming into today.
  • MYOV had returned +86.71% year-to-date leading up to today’s news, versus a +5.40% return from the benchmark S&P 500 during the same period.

More Info About Myovant Sciences Ltd. Common Shares (MYOV)


Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women’s health diseases and other endocrine-related disorders. The company was founded in 2016 and is based in Hamilton, Bermuda. View our full MYOV ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

MYOV at a Glance

MYOV Current POWR Rating™
Overall POWR Rating™
MYOV Current Price $20.49 2.43%
More MYOV Ratings, Data, and News

MYOV Price Reaction

The day of this event (Jul. 11, 2018)
MYOV Closing Price$24.10 2.12%
MYOV Volume65,900
16.74% from avg
Leading up to this event
MYOV 1-mo return7.86%
After this event
MYOV 1-day return2.39%
MYOV 3-day return15.18%

MYOV Price Chart



More Myovant Sciences Ltd. Common Shares (MYOV) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All MYOV News
Page generated in 0.9529 seconds.